510(k) device
RayStation (2024A SP3)
RaySearch Laboratories AB (PUBL) · System, Planning, Radiation Therapy Treatment (MUJ, Class II) · First FDA decision Apr 8, 2016, newest Dec 22, 2025Cancer radiation therapy
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
510(k) pathway
Device trials
0
Naming "RayStation"
MAUDE reports
99
Brand "RayStation", since 2015
PubMed studies
453
Mentioning "RayStation"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing RayStation (2024A SP3)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- RayStation (2024A SP3)510(k)
K252109 · Decided Dec 22, 2025 · 168 days after receipt
Device type: System, Planning, Radiation Therapy Treatment (MUJ) · Radiology & Imaging
4 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40168Wellpoint FederalUpdated Jul 14, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40179CGS Administrators, LLCUpdated Apr 17, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40193WPS Insurance CorporationUpdated Mar 12, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40189Palmetto GBAUpdated Mar 11, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40176Noridian Healthcare Solutions, LLCUpdated Mar 10, 2026
- Autologous Cellular Immunotherapy Treatment of Metastatic Prostate CancerNational analysisReview closedCAG-00422NUpdated Nov 19, 2026
- Hyperbaric Oxygen Therapy for Chronic Radiation Induced Proctitis and EnteritisNational analysisReview closedCAG-00060R2Updated Nov 18, 2026
- Electrical Stimulation (ES) and Electromagnetic Therapy for the Treatment of WoundsNational determinationOn the books270.1Updated Nov 4, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "RayStation", any status and sponsor, newest update first.
No registered device study names "RayStation".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "RayStation", and for the whole product code for context.
This brand
99 reports: 77 malfunction, 20 injury, 0 death
Whole product code MUJ
305 reports: 245 malfunction, 49 injury, 5 death
Newest reports for this brand
- RayStationMalfunction
RaySearch Laboratories AB (Publ)
3007774465-2026-00003 · Received Sep 22, 2026 · Event dated Jul 9, 2026
Device type: System, Planning, Radiation Therapy Treatment (MUJ)
Device problem as coded: Computer Software Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2488-2025 · Started Aug 8, 2025 · Posted by FDA Sep 2, 2025
Reason given: DICOM SOP Instance UID and Series Instance UID from RayGateway, i.e. the interface to Accuray's iDMS, are not guaranteed to be unique.
Cause as FDA categorized it: Under Investigation by firm · Device type: System, Planning, Radiation Therapy Treatment (MUJ)
57 more recall records with a free account
Published research
The most relevant PubMed records for "RayStation"[tiab]. The summary above synthesizes these.
- RayStation/GATE Monte Carlo simulation framework for verification of proton therapy based on the12N imaging.
Ahmadi Ganjeh Z, Zapien-Campos B, Traneus E, et al. · Phys Med Biol · 2024Research Support, Non-U.S. Gov't
- Treatment plan optimisation for reirradiation.
Murray L, Thompson C, Pagett C, et al. · Radiother Oncol · 2023Research Support, Non-U.S. Gov't
- RayStation: External beam treatment planning system.
Bodensteiner D · Med Dosim · 2018
- Evaluation of the RayStation electron Monte Carlo dose calculation algorithm.
Richmond N, Allen V, Wyatt J, et al. · Med Dosim · 2020Validation Study
- Validation of RayStation Monte Carlo dose calculation algorithm for multiple LINACs.
Manco L, Vega K, Maffei N, et al. · Phys Med · 2023
- Linking RayStation AI auto-contouring with Eclipse TPS: a scripted workflow for clinical integration.
Ryczkowski A, Jodda A, Piotrowski T · Rep Pract Oncol Radiother · 2025
- Commissioning and validation of RayStation treatment planning system for CyberKnife M6.
Gondré M, Conrad M, Vallet V, et al. · J Appl Clin Med Phys · 2022
- Comparative Study of Eclipse and RayStation Multi-Criteria Optimization-Based Prostate Radiotherapy Treatment Planning Quality.
Wong JYK, Leung VWS, Hung RHM, et al. · Diagnostics (Basel) · 2024
- Commissioning of a RayStation structure template for the iBEAM evo Couchtop.
Moutrie V, Walker A · Phys Eng Sci Med · 2023
- Treatment planning of scanned proton beams in RayStation.
Janson M, Glimelius L, Fredriksson A, et al. · Med Dosim · 2024
- The Raystation conversation: Multidisciplinary perceptions about training, leadership, and communication during implementation of new technology.
Dhillon H, Shessel A, Moyo E, et al. · J Med Imaging Radiat Sci · 2021
- Raystation Monte Carlo application: evaluation of electron calculations with entry obliquity.
Archibald-Heeren B, Liu G · Australas Phys Eng Sci Med · 2016
Other devices of this type
Also filed under product code MUJ.
- Eclipse Treatment Planning System (18.1)Varian Medical Systems · 510(k) 2024
- syngo.via RT Image SuiteSiemens Medical Solutions USA, Inc. · 510(k) 2024
- RT Elements (4.5)Brainlab AG · 510(k) 2025
- Monaco RTP System (6.3)Elekta Solutions AB · 510(k) 2026
- Corvus Radiation Therapy Planning SystemBest Nomos · 510(k) 2021
- Cyberknife Robotic Radiosurgery SystemAccuray, Inc. · 510(k) 2006
- ClearCalc Model RADCA V2.6Radformation, Inc. · 510(k) 2025
- OncospaceOncospace, Inc. · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.